Abstract
To analyze cases of therapy-related acute myeloid leukemia and myelodysplastic syndrome diagnosed after chemotherapy for refractory testicular and extragonadal germ cell tumor in our experience. A total of 171 consecutive patients who were diagnosed and treated as refractory germ cell tumor and had records of detailed chemotherapy doses between April 1998 and December 2015 were retrospectively reviewed. Four testicular tumor patients (4/171, 2.3%) developed therapy-related acute myeloid leukemia and myelodysplastic syndrome. Three of them were affected after complete remission of the primary testicular tumor. A median time interval from a start of chemotherapy to a secondary tumor development was 6.8 years (range 3.7-11.5 years). The median total dose of etoposide, ifosfamide, cisplatin and nedaplatin were 3640 mg/m2 (range 2906-4000 mg/m2 ), 42.7 g (range 19.5-54.0 g), 1100 mg/m2 (range 600-1500 mg/m2 ) and 500 mg/m2 (range 300-1600 mg/m2 ), respectively. Etoposide had the only significant relationship between a cumulative dose and leukemogenesis in univariate analysis (P < 0.05). One patient had complete remission, but the other three patients died. The present findings show that refractory germ cell tumor patients have an in...Continue Reading
References
Aug 10, 1991·Lancet·J Pedersen-BjergaardM Rørth
Dec 18, 1996·Journal of the National Cancer Institute·C L ChenM V Relling
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C KollmannsbergerC Bokemeyer
Feb 4, 1999·The New England Journal of Medicine·L B TravisM Stovall
Jul 25, 2000·Journal of the National Cancer Institute·L B TravisE Gilbert
Nov 28, 2002·Leukemia·N MauritzsonB Johansson
Apr 1, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Merel R van DijkJ Dik F Habbema
Nov 11, 2006·International Journal of Cancer. Journal International Du Cancer·Lorenzo RichiardiPaul Brennan
Apr 25, 2008·Annals of Epidemiology·Regan HowardLois B Travis
Apr 14, 2010·Blood·David GrimwadeUNKNOWN National Cancer Research Institute Adult Leukaemia Working Group
Apr 12, 2011·Cancer·Tomas BuchlerJitka Abrahamova
May 16, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Valentina NardiRobert P Hasserjian
Aug 2, 2012·International Journal of Environmental Research and Public Health·Sachiko Ezoe
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hege S HaugnesSophie D Fosså
Apr 15, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Tsuneharu MikiYukio Homma
Mar 20, 2015·Medicine·Terukazu NakamuraTsuneharu Miki
Citations
Oct 1, 2018·International Journal of Urology : Official Journal of the Japanese Urological Association·Toshiaki Tanaka, Naoya Masumori
Jun 21, 2020·Cancers·João LoboRui Henrique
Jun 6, 2018·International Journal of Urology : Official Journal of the Japanese Urological Association·Takeshi Kishida
Nov 21, 2020·International Journal of Molecular Sciences·Luisa GesualdiAngela Catizone
Jan 7, 2021·Indian Journal of Cancer·Manveen KaurKislay Dimri